Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The queried name "AdtecRF" most likely refers to the Adtec group, whose healthcare-focused business is Adtec Healthcare, a UK-based medical device company spun out from Japan's Adtec Plasma Technology. The company develops and commercializes cold plasma wound-care and infection-control devices, with SteriPlas as its flagship marketed system and PlasmaTact as a related handheld platform. Its technology is positioned as a non-antibiotic, non-invasive approach for chronic wounds, biofilm-associated infections, and selected dermatology applications. Adtec Healthcare reports clinical use in hospitals, published clinical evidence, and ongoing expansion supported by a 2025 financing round intended to fund U.S. regulatory progress, manufacturing scale-up, and broader international commercialization. Separately, "Adtec RF" is also used for the broader industrial RF power business of Adtec Plasma Technology, which is not primarily a life-science company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AdtecRF.